Cite
HARVARD Citation
Adachi, M. et al. (2018). Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan. Respiratory medicine. pp. 56-63. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Adachi, M. et al. (2018). Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan. Respiratory medicine. pp. 56-63. [Online].